The regulatory landscape for CRISPR technology in farming is complex and varies across regions. Some countries, such as the United States, have a relatively relaxed approach, treating CRISPR-edited crops similarly to those developed through traditional breeding. In contrast, the European Union has stringent regulations, classifying them as GMOs and subjecting them to rigorous safety assessments. These discrepancies pose challenges for global trade and the harmonization of safety standards.
